Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
Island Pharmaceuticals Ltd banner

Island Pharmaceuticals Ltd
ASX:ILA

Watchlist Manager
Island Pharmaceuticals Ltd Logo
Island Pharmaceuticals Ltd
ASX:ILA
Watchlist
Price: 0.37 AUD -3.9% Market Closed
Market Cap: AU$99.5m
Write Note Create Alert Ask AI

Island Pharmaceuticals Ltd
Investor Relations

Island Pharmaceuticals Ltd. is a drug research and repurposing company, focused on developing preventative or therapeutic drugs for viral infections. The company is headquartered in Melbourne, Victoria. The company went IPO on 2021-04-13. The firm focuses on developing preventative or therapeutic drugs for viral infections. Its lead product candidate ISLA-101, is a drug developed for the prevention and treatment of dengue fever and other mosquito (or vector) borne diseases. Its ISLA-101 is an antiviral oral drug to treat mosquito-borne viruses and is in Phase II of the clinical program.

Show more
Loading
ILA
S&P/ASX 300
1Y 3Y 5Y 10Y 15Y 20Y
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Dr. David Charles Foster J.D., M.A.I.C.D., Ph.D.
MD, CEO, President & Executive Director
No Bio Available
Mr. Cameron Jones C.A.
CFO & Company Secretary
No Bio Available

Contacts

Address
VICTORIA
Melbourne
697 Burke Road, Camberwell, Suite 201
Contacts
islandpharmaceuticals.com
sparklesyt

See Also

Summary
ILA intrinsic value, competitors valuation, and company profile.
DCF Valuation
ILA stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ILA stock valuation using valuation multiples.
Wall Street Estimates
ILA price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ILA stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Back to Top
ALPHA SPREAD
Follow us
Join more than 318,100+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.